|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/11/22 Accolade, Inc. 10-Q 11/30/21 68:9.1M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.52M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
10: R1 Document and Entity Information HTML 77K
11: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 110K
12: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 29K
(Parenthetical)
13: R4 Condensed Consolidated Statements of Operations HTML 85K
(Unaudited)
14: R5 Condensed Consolidated Statements of Convertible HTML 134K
Preferred Stock and Stockholders' Equity (Deficit)
(Unaudited)
15: R6 Condensed Consolidated Statements of Convertible HTML 22K
Preferred Stock and Stockholders' Deficit
(Unaudited) (Parenthetical)
16: R7 Condensed Consolidated Statements of Cash Flows HTML 127K
(Unaudited)
17: R8 Background HTML 23K
18: R9 Basis of Presentation and Summary of Significant HTML 67K
Accounting Policies
19: R10 Revenue HTML 44K
20: R11 Acquisitions HTML 130K
21: R12 Goodwill and Intangible Assets HTML 57K
22: R13 Fair Value Measurements HTML 74K
23: R14 Debt HTML 45K
24: R15 Equity-based Compensation HTML 122K
25: R16 Income Taxes HTML 27K
26: R17 Net Loss Per Share Attributable to Common HTML 100K
Stockholders
27: R18 Commitments and Contingencies HTML 26K
28: R19 Change Healthcare Joint Development Agreement HTML 34K
29: R20 Basis of Presentation and Summary of Significant HTML 83K
Accounting Policies (Policies)
30: R21 Basis of Presentation and Summary of Significant HTML 55K
Accounting Policies (Tables)
31: R22 Revenue (Tables) HTML 29K
32: R23 Acquisitions (Tables) HTML 109K
33: R24 Goodwill and Intangible Assets (Tables) HTML 58K
34: R25 Fair Value Measurements (Tables) HTML 74K
35: R26 Debt (Tables) HTML 26K
36: R27 Equity-based Compensation (Tables) HTML 116K
37: R28 Net Loss Per Share Attributable to Common HTML 101K
Stockholders (Tables)
38: R29 Change Healthcare Joint Development Agreement HTML 29K
(Tables)
39: R30 Basis of Presentation and Summary of Significant HTML 39K
Accounting Policies - Basis of Presentation and
Principles of Consolidation (Details)
40: R31 Basis of Presentation and Summary of Significant HTML 30K
Accounting Policies - Capitalized Internal-Use
Software Costs (Details)
41: R32 Basis of Presentation and Summary of Significant HTML 39K
Accounting Policies - Concentration of Credit Risk
(Details)
42: R33 Revenue - Revenue and Deferred Revenue (Details) HTML 38K
43: R34 Revenue - Revenue and Deferred Revenue Narratives HTML 25K
(Details)
44: R35 Revenue - Cost to obtain and fulfill a contract HTML 39K
(Details)
45: R36 Acquisitions - Summary of Purchase Consideration HTML 42K
(Details)
46: R37 Acquisitions - Shares Issued (Details) HTML 207K
47: R38 Acquisitions - Summary of Estimated Fair Values of HTML 112K
Assets Acquired and Liabilities Assumed (Details)
48: R39 Goodwill and Intangible Assets - Carrying amount HTML 25K
of goodwill (Details)
49: R40 Goodwill and Intangible Assets - Intangible assets HTML 63K
(Details)
50: R41 Fair Value Measurements (Details) HTML 39K
51: R42 Fair Value Measurements - Level 3 Contingent HTML 27K
Consideration (Details)
52: R43 Debt - Notes (Details) HTML 29K
53: R44 Debt (Details) HTML 142K
54: R45 Equity-based Compensation - Compensation expense HTML 33K
(Details)
55: R46 Equity-based Compensation - Stock Options HTML 70K
(Details)
56: R47 Equity-based Compensation - Stock Option Activity HTML 85K
(Details)
57: R48 Equity-based Compensation - Restricted Stock Units HTML 102K
(Details)
58: R49 Equity-based Compensation - Employee Stock HTML 47K
Purchase Plan (Details)
59: R50 Income Taxes (Details) HTML 34K
60: R51 Net income (Loss) Per Share Attributable to Common HTML 60K
Stockholders (Details)
61: R52 Net income (Loss) Per Share Attributable to Common HTML 50K
Stockholders - Stock Options (Details)
62: R53 Commitments and Contingencies - Legal Proceedings HTML 32K
(Details)
63: R54 Change Healthcare Joint Development Agreement HTML 56K
(Details)
66: XML IDEA XML File -- Filing Summary XML 123K
64: XML XBRL Instance -- accd-20211130x10q_htm XML 2.15M
65: EXCEL IDEA Workbook of Financial Reports XLSX 93K
6: EX-101.CAL XBRL Calculations -- accd-20211130_cal XML 170K
7: EX-101.DEF XBRL Definitions -- accd-20211130_def XML 660K
8: EX-101.LAB XBRL Labels -- accd-20211130_lab XML 1.42M
9: EX-101.PRE XBRL Presentations -- accd-20211130_pre XML 1.00M
5: EX-101.SCH XBRL Schema -- accd-20211130 XSD 180K
67: JSON XBRL Instance as JSON Data -- MetaLinks 353± 550K
68: ZIP XBRL Zipped Folder -- 0001558370-22-000200-xbrl Zip 341K
 | Download this Microsoft® Excel® .xlsx workbook |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/21 Accolade, Inc. 8-K:1,3,8,9 6/09/21 12:1.5M Toppan Merrill/FA 3/29/21 Accolade, Inc. 8-K:1,2,3,8 3/23/21 14:1.3M Toppan Merrill/FA 3/04/21 Accolade, Inc. 8-K:1,3,8,9 3/03/21 13:1.5M Toppan Merrill/FA 7/10/20 Accolade, Inc. 8-K:5,9 7/07/20 2:58K Toppan Merrill/FA 2/28/20 Accolade, Inc. S-1 39:24M Toppan Merrill-FA |